Where we run first-in-human trials across the Americas
The first-in-human CRO for the Americas. Where bioaccess® runs first-in-human and early feasibility trials: Mexico, Central America, the Caribbean and South America, plus an affiliated Miami cardiovascular site for Phase 1 and early device studies.
We activate the right investigators, sites and regulatory resources on demand, anywhere in the Americas, from Canada to Argentina.
bioaccess® supports medtech, biotech/biopharma and radiopharma first-in-human and early feasibility trials — devices, drugs, biologics and radiopharmaceuticals — across the Americas.
Where we run programs
- 🇺🇸 U.S. (affiliated Miami site) — Affiliated Miami cardiovascular site for Phase 1 and early device studies. FDA / IRB.
- 🇨🇴 Colombia — First-in-human and early feasibility programs
- 🇵🇦 Panama — First-in-human and early feasibility programs
- 🇸🇻 El Salvador — First-in-human and early feasibility programs
- 🇩🇴 the Dominican Republic — First-in-human and early feasibility programs
- 🇲🇽 Mexico — First-in-human and early feasibility programs
- 🇧🇷 Brazil — First-in-human and early feasibility programs
- 🇨🇷 Costa Rica — First-in-human and early feasibility programs
- 🇵🇾 Paraguay — First-in-human and early feasibility programs
- 🇨🇱 Chile — First-in-human study starting
Support on request
Device registration and market access cover 19 Latin American & Caribbean countries.
First-in-Human CRO · Contact bioaccess®